Immunological predictive and prognostic factors in patients with stage II-III triple negative breast cancer.

Olga Gordeeva,I. V. Kolyadina,A. I. Chertkova,Esma Shoua,Kadagidze Zg,E. G. Slavina,T. N. Zabotina,Yana V Vishnevskaya,I.P. Ganshina,Lyudmila Zhukova,Andrey Meshcheryakov

Immunological predictive and prognostic factors in patients with stage II-III triple negative breast cancer.

2020

Olga Gordeeva
I. V. Kolyadina
A. I. Chertkova
Esma Shoua
Kadagidze Zg
E. G. Slavina
T. N. Zabotina
Yana V Vishnevskaya
I.P. Ganshina
Lyudmila Zhukova
Andrey Meshcheryakov

e12581Background: Triple negative breast cancer (TNBC) is the most aggressive subtype of breast cancer. Pathologic complete response (pCR) achievement during neoadjuvant chemotherapy (NACT) is very...

Keywords:

Oncology
Triple-negative breast cancer
Internal medicine
in patient
stage ii
Pathology
Medicine
Breast cancer
complete response
Chemotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations